Anti-IL-5 biologics carve out severe-asthma niche.
Elie
E
Dolgin
D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D007249:Inflammation / Q000188:drug therapy* / Q000235:genetics; D015848:Interleukin-5 / Q000037:antagonists & inhibitors; D058990:Molecular Targeted Therapy
D061067:Antibodies, Monoclonal, Humanized; C508599:IL5 protein, human; D015848:Interleukin-5; C434107:mepolizumab